HRCT and pulmonary function tests in monitoring of lung involvement in juvenile systemic sclerosis

Pediatric Pulmonology

Volumn 44, Issue 12, 2009, Pages 1226-1234

  Panigada, Serena ^a   Ravelli, Angelo ^a,b   Silvestri, Michela ^a   Granata, Claudio ^a   Magni Manzoni, Silvia ^c   Cerveri, Isa ^c   Dore, Roberto ^c   Tomà, Paolo ^a   Martini, Alberto ^a,b   Rossi, Giovanni A ^a   Sacco, Oliviero ^a  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

High resolution CT; Interstitial lung disease; Juvenile systemic sclerosis; Pulmonary function tests

Indexed keywords

CARBON MONOXIDE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; METHOTREXATE; PENICILLAMINE;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FORCED EXPIRATORY VOLUME; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG FUNCTION TEST; MALE; PATIENT MONITORING; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SYSTEMIC SCLEROSIS;

ADOLESCENT; CHILD; FEMALE; HUMANS; LUNG DISEASES; MALE; RESPIRATORY FUNCTION TESTS; SCLERODERMA, SYSTEMIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 73449129040     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21141     Document Type: Article

References (42)

1. Black CM, Stephen C. In: Maddison PJ, Isenberg DA, Woo P, Glass DN, editors. Systemic sclerosis (scleroderma) and related disorders. In: Maddison PJ, Isenberg DA, Woo P, Glass DN, editors, Oxford textbook of rheumatology. Oxford: Oxford University Press: 1993. p. 771-789.
2. Zulian F. Scleroderma in children. Pediatr Clin North Am 2005; 52:521-545, vii.
3. Martini G, Foeldvari I, Russo R, Cuttica R, Eberhard A, Ravelli A, Lehman T, de Oliveira S, Susic G, Lyskina G, Nemcova D, Sundel R, Falcini F, Girschick H, Lotito A, Buoncompagni A, Sztajnbok F, Al-Mayouf S, Orbàn I, Ferri C, Athreya B, Woo P, Zulian F. Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database. Arthritis Rheum 2006;54:3971-3978.
4. Foeldvari I, Zhavania M, Birdi N, Cuttica R, de Oliveira S, Dent P, Elborgh R, Falcini F, Ganser G, Girschick H, Häfner R, Joos R, Kuis W, Pelkonen P, Prieur A, Rostropowicz-Denisiewicz K, Russo R, Savolainen A, Siamopoulou-Mayridou A, Zulian F. Favourable outcome in 135 children with juvenile systemic sclerosis: results of a multi-national survey. Rheumatology (Oxford) 2000;39:556-559.
5. Steen V. Predictors of end stage lung disease in systemic sclerosis. Ann Rheum Dis 2003;62:97-99.
6. Jacobsen S, Ullman S, Shen G, Wiik A, Halberg P. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis. J Rheumatol 2001; 28:2454-2459.
7. Martini G, Vittadello F, Kasapçopur O, Magni Manzoni S, Corona F, Duarte-Salazar C, Nemcova D, Len CA, Garay SM, Ullman S, Zulian F, Juvenile Scleroderma Working Group of Paediatric Rheumatology European Society (PRES). Factors affecting survival in juvenile systemic sclerosis. Rheumatology (Oxford) 2009;48:119-122.
8. du Bois R. Mechanisms of scleroderma-induced lung disease. Proc Am Thorac Soc 2007;4:434-438.
9. Warrick J, Bhalla M, Schabel S, Silver R. High resolution computed tomography in early scleroderma lung disease. J Rheumatol 1991;18:1520-1528.
10. Schurawitzki H, Stiglbauer R, Graninger W, Herold C, Pölzleitner D, Burghuber O, Tscholakoff D. Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography. Radiology 1990;176:755-759.
11. Remy-Jardin M, Remy J, Wallaert B, Bataille D, Hatron P. Pulmonary involvement in progressive systemic sclerosis: sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage. Radiology 1993;188:499-506.
12. White B. Interstitial lung disease in scleroderma. Rheum Dis Clin North Am 2003;29:371-390.
13. Denton CP. Therapeutic targets in systemic sclerosis. Arthritis Res Ther 2007;9(Suppl 2):S6.
14. Bouros D, Wells A, Nicholson A, Colby T, Polychronopoulos V, Pantelidis P, Haslam P, Vassilakis D, Black C, du Bois R. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002;165:1581-1586.
15. Seely J, Jones L, Wallace C, Sherry D, Effmann E. Systemic sclerosis: using high-resolution CT to detect lung disease in children. Am J Roentgenol 1998;170:691-697.
16. Wells A, Hansell D, Corrin B, Harrison N, Goldstraw P, Black C, du Bois R. High resolution computed tomography as a predictor of lung histology in systemic sclerosis. Thorax 1992;47:738-742.
17. Owens C. Radiology of diffuse interstitial pulmonary disease in children. Eur Radiol 2004;14(Suppl 4):2-12.
18. Cerveri I, Bruschi C, Ravelli A, Zoia MC, Fanfulla F, Zonta L, Pellegrini G, Martini A. Pulmonary function in childhood connective tissue diseases. Eur Respir J 1992;5:733-738.
19. Guttadauria M, Ellman H, Emmanuel G, Kaplan D, Diamond H. Pulmonary function in scleroderma. Arthritis Rheum 1977;20: 1071-1079.
20. Owens G, Fino G, Herbert D, Steen V, Medsger TJ, Pennock B, Cottrell J, Rodnan G, Rogers R. Pulmonary function in progressive systemic sclerosis. Comparison of CREST syndrome variant with diffuse scleroderma. Chest 1983;84:546-550.
21. Della Rossa A, Valentini G, Bombardieri S, Bencivelli W, Silman A, D'Angelo S, Cerinic M, Belch J, Black C, Becvar R, Bruhlman P, Cozzi F, Czirják L, Drosos A, Dziankowska B, Ferri C, Gabrielli A, Giacomelli R, Hayem G, Inanc M, McHugh N, Nielsen H, Scorza R, Tirri E, van den Hoogen F, Vlachoyiannopoulos P. European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres. Ann Rheum Dis 2001; 60:585-591.
22. Varga J, Trojanowska M. Fibrosis in systemic sclerosis. Rheum Dis Clin North Am 2008;34:115-143.
23. Renzoni E. Interstitial lung disease in systemic sclerosis. Monaldi Arch Chest Dis 2007;67:217-228.
24. Kaloudi O, Miniati I, Alari S, Matucci-Cerinic M. Interstitial lung disease in systemic sclerosis. Intern Emerg Med 2007;2:250-255.
25. Goldin JG, Lynch DA, Strollo DC, Suh RD, Schraufnagel DE, Clements PJ, Elashoff RM, Furst DE, Vasunilashorn S, McNitt-Gray MF, Brown MS, Roth MD, Tashkin DP, Scleroderma Lung Study Research Group. High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease. Chest 2008;134:358-367.
26. Bellia M, Cannizzaro F, Scichilone N, Riili M, Triolo G, Midiri M, Lagalla R. HRCT and scleroderma: semiquantitative evaluation of lung damage and functional abnormalities. Radiol Med 2009;114:190-203.
27. Szamosi S, Maródi L, Czirják L, Ellenes Z, Szücs G. Juvenile systemic sclerosis: a follow-up study of eight patients. Ann NY Acad Sci 2005;1051:229-234.
28. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-590.
29. Zulian F, Woo P, Athreya BH, Laxer RM, Medsger TA, Jr., Lehman TJ, Cerinic MM, Martini G, Ravelli A, Russo R, Cuttica R, de Oliveira SK, Denton CP, Cozzi F, Foeldvari I, Ruperto N. The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis. Arthritis Rheum 2007;57:203-212.
30. LeRoy E, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TJ, Rowell N, Wollheim F. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-205.
31. Cotes JE. Lung function assessment and application in medicine. 4th edition. London: Blackwell; 1979.
32. Keogh B, Crystal R. Clinical significance of pulmonary function tests. Pulmonary function testing in interstitial pulmonary disease. What does it tell us? Chest 1980;78:856-865.
33. Diot E, Boissinot E, Asquier E, Guilmot JL, Lemarié E, Valat C, Diot P. Relationship between abnormalities on high-resolution CT and pulmonary function in systemic sclerosis. Chest 1998;114: 1623-1629.
34. Harrison N, Glanville A, Strickland B, Haslam P, Corrin B, Addis B, Lawrence R, Millar A, Black C, Turner-Warwick M. Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance. Respir Med 1989;83:403-414.
35. Launay D, Remy-Jardin M, Michon-Pasturel U, Mastora I, Hachulla E, Lambert M, Delannoy V, Queyrel V, Duhamel A, Matran R, De Groote P, Hatron PY. High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis. J Rheumatol 2006;33:1789-1801.
36. Suárez-Almazor M, Catoggio L, Maldonado-Cocco J, Cuttica R, García-Morteo O. Juvenile progressive systemic sclerosis: clinical and serologic findings. Arthritis Rheum 1985;28:699-702.
37. Martini A, Maccario R, Ravelli A, Montagna D, De Benedetti F, Bonetti F, Viola S, Zecca M, Perotti C, Locatelli F. Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis. Arthritis Rheum 1999;42:807-811.
38. Abramson MJ, Barnett AJ, Littlejohn GO, Smith MM, Hall S. Lung function abnormalities and decline of spirometry in scleroderma: an overrated danger? Postgrad Med J 1991;67: 632-637.
39. Vilozni D, Efrati O, Hakim F, Adler A, Livnat G, Bentur L. FRC measurements using body plethysmography in young children. Pediatr Pulmonol 2009;44:885-891.
40. Gardner R, Crapo R, Teculescu D. Standardization of spirometry and single breath DL(CO) tests. Eur Respir J 1988;1:293-296.
41. Suman O, Thomas S, Beck K, Mlcak R, Herndon D. Comparison of carbon monoxide (CO) single breath pulmonary diffusing capacity with non-rebreathing, open-circuit CO pulmonary diffusing capacity in healthy children. Pediatr Pulmonol 2006; 41:1095-1102.
42. Steen VD, Graham G, Conte C, Owens G, Medsger TA, Jr. Isolated diffusing capacity reduction in systemic sclerosis. Arthritis Rheum 1992;35:765-767.